Tzds PowerPoint PPT Presentations

CV Risk Reduction, Diabetes Prevention, and TZDs

TZDs and Atherosclerosis: Evolution from Translational to Clinical Science

Not too long ago we were hunters and gatherers doing physical labor for our ... Postprandial blood glucose. Fasting blood glucose. Typical diagnosis of diabetes ...

Harvard Business School Press, Boston Massachusetts, 2006. 4. The Mission of ... 5. Proportion of Days Covered: Diabetes Meds (Sulphonylureas, Biguanides, TZDs) ...

Useful in combo RX. Improves Insulin resistance at the hepatic level. TZDs Improve CV Risks ... CARDS, Collaborative Atorvastatin Diabetes Study. Colhoun HM, ...

Combination oral hypoglycemic therapy. Insulin use. Use of a ... High Density Lipoprotein (HDL) Cholesterol Particle Concentration. TZDs & Lipoprotein Particles ...

Review internal & syndicated data. What do you know already? ... Clinical trials with TZDs and DPP4s support ability to prevent progression to full diagnosis ...

Thiazolidinediones Inhibit Aromatase Activity in Human Granulosa Cells by Interfering with Androgen Binding to Aromatase Takako Araki M.D. Dimiter Avtanski PhD

Title: Thiazolidinedione and bone turnover Author: Dell Last modified by: Administrator Document presentation format: On-screen Show Other titles

Thiazolidinediones interact with Abiraterone, Pixantrone, Azole Antifungals, Fibrates, Teriflunomide, Dabrafenib and Rifampin. Pioglitazone also interacts with Calcium channel blockers (Nifedipine, Amlodipine), Cobicistat, Piperaquine, Ifosfamide, Tolvaptan, Midazolam, Tipranavir/Ritonavir, Macrolide antibiotics, Sulphonamides, Amiodarone, Topiramate, Oral contraceptives, Atorvastatin, Danazol and Trandolapril.

Aggressive medical therapy in diabetes. Adapted from Beckman JA ... Fibric acid derivatives. ACE inhibitors. ARBs. -blockers. CCBs. Diuretics. ASA. Clopidogrel ...

Title: Vitamin D Intoxication due to Manufacturing and Labeling Errors of a Dietary Supplement: A Case Report Author: Takako Araki Last modified by

Glucose. Independent. Insulin Secretion. Beta Protective. Metformin & TLC. Insulin Efficacy ... Glu Dep Insulin -Upper Resp Inf. Glinides -Cost. A1C 1.5. A1C 1.0 ...

... A1c on Cardiovascular Disease in T2DM Insulin Resistance Is Associated With or Directly Responsible for Factors Causing Atherothrombosis UKPDS 35: ...

Metabolic Syndrome Endocrine Block 1 Lecture Dr. Usman Ghani Overview Introduction Features of metabolic syndrome Insulin resistance Dyslipidemia Risk factors Markers ...

Diabetes in Ramadan Meta-analysis of 92 studies on fasting Ramadan in Diabetic patients Abbas Orabi The patients of 92 studies have been enrolled in the ongoing meta ...

Learn the horrible effects your diabetes medicine have on your health and also know the secret to avoid the medicines and take controll of your life.

... factors. 3 subtypes. PPAR a -liver and skeletal muscle ... Kidney cells from male adult African green monkey. PPAR cDNA placed in expression vector (pSG5) ...

Comparing Medications for Adults With Type 2 Diabetes Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Adverse Events and Side Effects ...

Glucose. Independent. Insulin Secretion. Beta Protective ... Upper Resp Inf. Glinides -Cost. A1C 1.5. A1C 1.0. May combine up to max three oral agents ...

... azotemia, a hstory of prior heart failure, and comorbid illnesses were ... CONGESTIVE ... if the pt exhibits signs of deterioration in cardiac status. ...

... Blood Glucose and Vascular Risk in Diabetes ACCORD and ADVANCE: ... Serum Creatinine and Glomerular Filtration The Concept of a Balanced Dual PPAR ...

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor g (PPARg) Jurgen Lehmann et al., 1995, Journal of ...

S ndrome caracterizado por la presencia de hiperglucemia, asociada a ... Seg n American Association of Clinical Endocrinologists. OBJETIVOS DE CONTROL ...

AMP-activated protein kinase induces apoptosis in LX2 cells involving of Bax pathway Background Result Possible mechanism Next works Hepatic stellate cells (HSCs ...

Nichols GA, Diabetes Care 27:879, 2004; Gustafsson I et al. J Am Coll Cardiol 43: ... Scott M Grundy, MD, PhD; Edward S Horton, MD; Martin Le Winter, MD; Daniel Porte, ...

... Glicemia de ayuno 110 mg/dl y/o 2hr post-carga 140 mg/dl ... Triglic ridos 150 mg/dl. Colesterol de HDL (C-HDL) Hombres 35 mg/dl. Mujeres 39 mg/dl ...

The s would highlight the some of the recent developments in the field of nanobiotechnology regarding non-parenteral insulin delivery

Diabetes Mellitus Fifth Stage-Medicine Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management * * * * * * Comprehensive diabetes care of type 2 DM Patient ...

Diabetes Mellitus Dr. Ricardo Curc Historia Descrita en el manuscrito de Ebers en el 1500 BC, se presume, de casos de DM1. Madhumeda : India, orina dulce ...

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. For More Details: http://bit.ly/1Am23RE

The Regulation of Eukaryotic Gene Expression..using the example of PEPCK PEPCK This is an acronym for an enzyme PhosphoEnol Pyruvate CarboxyKinase This enzyme is ONLY ...

DIABETES MELLITUS Management

Drug interactions of Incretin mimetics (Exenatide) with other drugs like Warfarin, Digoxin, Paracetamol, Antibacterials, Thyroid hormones, Danazol and ACE inhibitors are dealt in this presentation. The interactions of Amylin analogue (Pramlintide) with other drugs such as Alpha glucosidase inhibitors, Danazol, ACE inhibitors, Thyroid hormones, Paracetamol and Antimuscarinics are also dealt in this presentation.

Title: PowerPoint Presentation Author: Dr. Robin Conway Last modified by: Guylaine Hardy Created Date: 2/4/2004 5:25:06 AM Document presentation format

DIABETES MELLITUS Management IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT Control: good / poor? Treatment? Complications ...

GI side effects (including diarrhea) are dose dependent. ... Alpha-glucosidase inhibitors (Acarbose and miglitol) decrease post-prandial hyperglycemia. ...

MANAGEMENT OF TYPE 2 DIABETES AND NEW NICE GUIDELINES Dr SUNIL ZACHARIAH CONSULTANT ENDOCRINOLOGIST INTRODUCTION The epidemic of type 2 diabetes and the recognition ...

Clinical Biochemistry of Metabolic Disorders - I Dr Vivion Crowley FRCPath FRCPI Consultant Chemical Pathologist St James s Hospital Dublin Parathyroid hormone ...

2 agents from different classes or insulin basal and/or preprandial. 9 ... FPG, preprandial and postprandial PG targets. Burden of Poor Control - Cost ...

Diabetic patients take Insulin and/or other oral hypoglycemic and antihyperglycemic drugs to control their blood sugar levels. Along with antidiabetic medicines they may take drugs such as OTC medicines, prescription medicines, etc.to treat other illnesses which may interact with them. Drug interactions of Insulin with other drugs like Fluoroquinolones, Betablockers, Aspirin, Thiazolidinediones, Antipsychotics, Androgens, Antimalarials and Orlistat are dealt in this presentation. The interactions of Insulin with Complementary and alternative medicines (CAM) such as Bitter melon, Ginkgo, Ginseng, Gymnema, Licorice and Fenugreek with smoking and with alcohol are also dealt in this presentation.

NO EVIDENCE No CV signal yet Lixizenatide Cancer ? NO EVIDENCE Needle SGLT2 Inhibitors Pros Cons Easily added to anything, and/or insulin in DM1 & 2 Simple & dose ...

Social Impact of. Modernization/ Westernization. Machine driven jobs ... Accounts for 43% of all cases of new onset renal failure per year ...

Pioglitazone has not been tested in patients with NYHA class III and IV cardiac status ... Pioglitazone (45 mg qd) LDL-C. HDL-C. TG. King AB. Diabetes Care 2000; ...

SGLT2 is the main site of filtered glucose reabsorption; reduction of filtered glucose reabsorption and lowering of RTG result in increased urinary excretion of ...

Based on 2 open-label trials, ... In other words, what percent of new users of each class (reading down), ... Probably closest to capturing true new diabetics ...

Cost Containment Strategies CDR Denise M. Graham, MSC, USN PEC Director of Clinical Operations Objectives Outline DoD cost containment strategies used during the last ...

Title: Adip cito como rg o end crino Author: AAEHSJ Last modified by: Windows User Created Date: 11/7/2006 11:46:50 PM Document presentation format

Hyperglycaemia. Dyslipidaemia. Inflammation. IR. Atherosclerosis, CVD. Microalbuminuria ... hyperglycaemia. RSG CRP. Rosiglitazone in diabetic coronary patient ...

Higher Testosterone Concentrations in Type 2 Diabetic Men Treated with Metformin Ajaz Banka , MBBS Sandeep Dhindsa , MD Paresh Dandona , MD Introduction One third of ...

Title: Slide 1 Author: vivion Last modified by: JFREEMAN Created Date: 2/12/2006 5:02:24 PM Document presentation format: On-screen Show Other titles

Title: PowerPoint Author: romeo Last modified by: ahassan Created Date: 9/5/2003 10:33:35 AM Document presentation format

Oral Treatments for Type 2 Diabetes Prescribing Support Pharmacist Glucose Homeostasis Glucose Homeostasis See NHSGGC guidelines on monitoring of blood glucose for ...

diabetes guidelines and treatment pcommednet family medicine residency intensive board review richard p. frey,do,mph,facofp dme and fp residency program director

Current perspectives on Lipodystrophy Mike Youle Director of HIV Research Royal Free Centre for HIV Medicine London, UK What is lipodystrophy? Lipodystrophies are ...

DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication Prevention of Type 2 Diabetes Clinical trials have shown that diet & exercise can ...